Adverum Biotechnologies, Inc.

ADVMDelisted Dec 9, 2025

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001501756

SEC filings (opens in a new tab)

Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Adverum Biotechnologies, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ADVM: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	58	61	+3
Shares	65.7M	65.3M	−397.9K (−0.6%)
Value	$104.4M	$97.9M	−$6.45M (−6.2%)

New holders (11)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ADVM in Q3 2023
Institution	Shares	Value	% of portfolio
Citigroup Inc	476,692	$715.0K	0.00%
Marshall Wace, LLP	237,331	$356.0K	0.00%
Jefferies Financial Group Inc.	75,000	$112.5K	0.00%
Man Group plc	–	$52.6K	0.00%
Qube Research & Technologies Ltd	24,967	$37.5K	0.00%
HRT Financial LP	25,098	$37.0K	0.00%
Captrust Financial Advisors	20,500	$30.8K	0.00%
Russell Investments Group, Ltd.	16,000	$24.0K	0.00%
American Century Companies Inc	13,058	$19.6K	0.00%
Northwestern Mutual Wealth Management Co	317	$476	0.00%
NBC Securities, Inc.	500	$0	0.00%

Sold out (8)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ADVM in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Soleus Capital Management, L.P.	320,000	$508.8K
Gsa Capital Partners LLP	122,676	$195.0K
Connor, Clark & Lunn Investment Management Ltd.	84,278	$134.0K
Bridgeway Capital Management, LLC	50,000	$79.5K
Group One Trading, L.P.	21,574	$34.3K
Occudo Quantitative Strategies LP	19,432	$30.9K
Wolverine Trading, LLC	13,258	$21.1K
Deutsche Bank AG	18	$29